Technical Analysis for NEOS - Neos Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.7 -5.56% -0.10
NEOS closed down 5.56 percent on Friday, May 17, 2019, on 1.8 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NEOS trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Doji - Bullish? Reversal -5.56%
Wide Bands Range Expansion -5.56%
Oversold Stochastic Weakness -5.56%
Wide Bands Range Expansion -5.03%
Lower Bollinger Band Touch Weakness -5.03%
Oversold Stochastic Weakness -5.03%

Older signals for NEOS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Neos Therapeutics, Inc., a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. Its product candidates are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets generic Tussionex, a hydrocodone polistirex and chlorpheniramine polistirex XR liquid suspension product indicated for the relief of cough and upper respiratory symptoms associated with allergies or colds in adults and children of six years of age and older. Its product candidates include NT-0102 methylphenidate XR orally disintegrating tablet for the treatment of ADHD; NT-0202 amphetamine XR orally disintegrating tablet for the treatment of ADHD; and NT-0201 amphetamine XR liquid suspension for the treatment of ADHD. The company is headquartered in Grand Prairie, Texas.
Pharmaceutical Drugs Pharmacology Euphoriants Psychoactive Drugs Attention Deficit Hyperactivity Disorder Cough Hydrocodone Adhd Allergies Treatment Of Attention Deficit Hyperactivity Disorder Amphetamine Drug Delivery Technologies Methylphenidate Nootropics
Is NEOS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 7.75
52 Week Low 1.4
Average Volume 437,032
200-Day Moving Average 3.1199
50-Day Moving Average 2.3706
20-Day Moving Average 2.153
10-Day Moving Average 1.992
Average True Range 0.1606
ADX 21.91
+DI 11.4539
-DI 31.2366
Chandelier Exit (Long, 3 ATRs ) 1.9682
Chandelier Exit (Short, 3 ATRs ) 2.1518
Upper Bollinger Band 2.6146
Lower Bollinger Band 1.6914
Percent B (%b) 0.01
BandWidth 42.879703
MACD Line -0.1518
MACD Signal Line -0.1009
MACD Histogram -0.0509
Fundamentals Value
Market Cap 47.74 Million
Num Shares 28.1 Million
EPS -4.30
Price-to-Earnings (P/E) Ratio -0.40
Price-to-Sales 18.06
Price-to-Book 10.86
PEG Ratio -0.04
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.87
Resistance 3 (R3) 1.87 1.83 1.84
Resistance 2 (R2) 1.83 1.78 1.82 1.83
Resistance 1 (R1) 1.76 1.76 1.74 1.76 1.82
Pivot Point 1.72 1.72 1.71 1.71 1.72
Support 1 (S1) 1.65 1.67 1.63 1.65 1.58
Support 2 (S2) 1.61 1.65 1.60 1.57
Support 3 (S3) 1.54 1.61 1.56
Support 4 (S4) 1.54